Investors Snag BHVN 5.9% Cheaper Than Its Secondary Stock Offering
June 20, 2019 at 09:58 AM EDT
Looking back to 2 days ago, Biohaven Pharmaceutical Holding Co Ltd (BHVN) priced a 6,976,745 share secondary stock offering at $43.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..